Success Story: NIW Approved Without RFE! Pakistani Associate Professor Achieves Success with Our Strategic Support

Client’s Testimonial:

“Thank you so much for sharing such wonderful and exciting news with me. I’m absolutely thrilled and incredibly grateful! I truly appreciate the exceptional professional support you provided throughout every stage of my NIW immigration process. From the very beginning, your guidance, clear communication, and attention to detail gave me confidence and peace of mind. Your expertise helped simplify what could have been an overwhelming process, and your responsiveness and encouragement made a significant difference. I especially want to acknowledge your consistent dedication, timely updates, and thoughtful handling of every part of my case. Your role in this successful outcome has been invaluable, and I am sincerely thankful for your efforts.”

On April 15^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Professor in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Associate Professor

Country of Origin: Pakistan

Country of Residence at the Time of Filing: Pakistan

Approval Notice Date: April 15^th, 2025

Processing Time: 1 year, 4 months, 2 days

Case Summary:

We are pleased to share the recent I-140 National Interest Waiver (NIW) approval for a highly accomplished PhD holder originally from Pakistan. This milestone highlights not only our client’s outstanding contributions to pharmaceutical sciences but also the power of a well-structured petition in securing immigration benefits for researchers working on projects of national significance.

Research Focus and Impact

Our client’s work lies at the intersection of pharmacology and natural product research, with a focus on developing non-synthetic therapeutic options for treating inflammation-related disorders, neurological diseases, chronic pain, and systemic conditions. By exploring bioactive compounds derived from traditional medicinal plants and leveraging innovative analytical methods, our client has built a compelling record of impactful research aimed at improving patient outcomes.

His future plans include designing natural compound-based therapeutics through computer-aided drug discovery, with an emphasis on treating Type 1 diabetes and neurological disorders – areas that represent significant public health concerns in the U.S.

Petition Category and Evidence of Excellence

The petition strategically demonstrated our client’s qualifications through:

● A robust publication record, including nearly 100 peer-reviewed journal articles and several book chapters,

● Over 3,400 citations, with numerous publications ranked among the most-cited papers in the field of Pharmacology & Toxicology for their publication years,

● At least 19 verified peer review assignments for leading journals in pharmacology, neuroscience, nanomedicine, and toxicology,

● Editorial board memberships with reputable journals, reflecting leadership and trust in his expertise,

● Research funding from major international institutions and government agencies underlines the global recognition of his work.

Letters of Recommendation

Two independent experts in pharmaceutical and medical research provided letters of recommendation, attesting to the originality and national value of the client’s work. Their statements strengthened the case for a waiver of the labor certification requirement based on national interest.

“It is clear that [Client] is an exceptional researcher at the top of the field of pharmaceutical sciences. His history of successful project outcomes is indicative of a uniquely skilled scientist. In addition, his work on identifying the neuroprotective and pain-relieving effects of natural products has provided others within the field with essential guidance for the development of new pharmaceuticals.”

Client’s Reflection on the Process

“I am delighted to share the exciting news of my National Interest Waiver (NIW) approval, and I would like to extend my heartfelt thanks to Chen Immigration Law Associates for their outstanding support and expertise throughout this journey.

As a researcher in the field of pharmaceutical sciences, I knew that preparing a successful NIW petition would require not only a strong presentation of my academic and research credentials but also an in-depth understanding of the complex immigration process. From the initial evaluation to the final approval, the Chen Immigration team demonstrated exceptional professionalism, clarity, and efficiency.

Their ability to translate technical details into a compelling legal argument was truly impressive. Thank you, Chen Immigration Law Associates, for making my NIW approval a reality.”

This approval highlights the critical role of research in natural therapeutics for national health priorities and exemplifies how targeted legal strategy and scientific excellence can come together to secure immigration benefits. We look forward to seeing our client’s continued contributions in the pharmaceutical and public health sectors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.